Papillary renal cell carcinoma: Clinicopathological characteristics in 40 patients

Clinical and Experimental Nephrology

Volumn 12, Issue 3, 2008, Pages 195-199

  Kosaka, Takeo ^a   Mikami, Shuji ^a   Miyajima, Akira ^a   Kikuchi, Eiji ^a   Nakagawa, Ken ^a   Ohigashi, Takashi ^a   Nakashima, Jun ^a   Oya, Mototsugu ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Histology; Immunotherapy; Papillary renal cell carcinoma

Indexed keywords

INTERLEUKIN 2;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; DRUG RESPONSE; FEMALE; HUMAN; KIDNEY CARCINOMA; MALE; PAPILLARY CARCINOMA; PATHOLOGY;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INTERLEUKIN-2; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEPHRECTOMY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 44149117472     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-008-0041-x     Document Type: Article

References (16)

1. Reuter VE, Presti JC Jr. Contemporary approach to the classification of renal epithelial tumors. Semin Oncol. 2000;27:124-37.
2. Renshaw AA, Corless CL. Papillary renal cell carcinoma. Histology and immunohistochemistry. Am J Surg Pathol. 1995;19:842-9.
3. Mydlo JH, Bard RH. Analysis of papillary renal adenocarcinoma. Urology. 1987;30:529-34.
4. Amin MB, Amin MB, Tamboli P, Javidan J, Stricker H, de-Peralta Venturina M, Deshpande A, Menon M. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol. 2002;26:281-91.
5. Moch H, Gasser T, Amin MB, Torhorst J, Sauter G, Mihatsch MJ. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer. 2000;89:604-14.
6. Onishi T, Ohishi Y, Goto H, Suzuki M, Miyazawa Y. Papillary renal cell carcinoma: clinicopathological characteristics and evaluation of prognosis in 42 patients. BJU Int. 1999;83:937-43.
7. Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol. 1997;10:537-44.
8. Allory Y, Ouazana D, Boucher E, Thiounn N, Vieillefond A. Papillary renal cell carcinoma. Prognostic value of morphological subtypes in a clinicopathologic study of 43 cases. Virchows Arch. 2003;442:336-42.
9. Delahunt B, Eble JN, McCredie MR, Bethwaite PB, Stewart JH, Bilous AM. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol. 2001;32:590-5.
10. Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am J Surg Pathol. 1997;21:621-35.
11. el-Naggar AK, Ro JY, Ensign LG. Papillary renal cell carcinoma: clinical implication of DNA content analysis. Hum Pathol. 1993;24:316-21.
12. Renshaw AA, Zhang H, Corless CL, Fletcher JA, Pins MR. Solid variants of papillary (chromophil) renal cell carcinoma: clinicopathologic and genetic features. Am J Surg Pathol. 1997;21:1203-9.
13. Yang XJ, Tan MH, Kim HL, Ditlev JA, Betten MW, Png CE, Kort EJ, Futami K, Furge KA, Takahashi M, Kanayama HO, Tan PH, Teh BS, Luan C, Wang K, Pins M, Tretiakova M, Anema J, Kahnoski R, Nicol T, Stadler W, Vogelzang NG, Amato R, Seligson D, Figlin R, Belldegrun A, Rogers CG, Teh BT. A molecular classification of papillary renal cell carcinoma. Cancer Res. 2005;65:5628-37.
14. Motzer RJ, Russo P. Systemic therapy for renal cell carcinoma. J Urol. 2000;163:408-17.
15. Mai KT, Landry DC, Robertson SJ, Commons AS, Burns BF, Thijssen A, Collins J. A comparative study of metastatic renal cell carcinoma with correlation to subtype and primary tumor. Pathol Res Pract. 2001;197:671-5.
16. Motzer RJ, Bacik J, Mariani T, Russo P, Mazumdar M, Reuter V. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol. 2002;20:2376-81.